Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis.

Cancer Control · 2022 · PMC8950026 · PMID 36748348

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

Only 2 studies had CI which did not cross value of 1, yet they were barely significant ( Figure 3(B) ).

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.